dominic_blakemore_shire

Shire hires finance director

pharmafile | October 28, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, dominic blakemore 

Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance & Risk Committee.

Blakemore is Group Finance director of Compass Group. Prior to this he was the chief financial officer at Iglo Foods Group and Finance & Strategy director of Cadbury.

Blakemore spent his earlier career years at PwC (PricewaterhouseCoopers), where his work included advising pharmaceutical sector clients.

Advertisement

Matthew Emmens, chairman of Shire said: “The Shire Board will benefit from Dominic’s strategic and financial experience. We look forward to him joining the Board.”

Blakemore added: “Shire has an excellent track record of growth and a clear strategy. I look forward to playing a part in this growing company’s future.”

Related Content

takeda_deerfield_hq

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end

Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, …

novartis_window

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger …

The Gateway to Local Adoption Series

Latest content